Literature DB >> 26962912

Treatment of Advanced Renal-Cell Carcinoma.

Olivier Huillard1, Jerome Alexandre1, François Goldwasser1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 26962912     DOI： 10.1056/NEJMc1515613

Source DB:  PubMed          Journal:  N Engl J Med        ISSN： 0028-4793            Impact factor:   91.245


× No keyword cloud information.
  3 in total

Review 1.  Spotlight on nivolumab in the treatment of renal cell carcinoma: design, development, and place in therapy.

Authors:  Vyshak Alva Venur; Monika Joshi; Kenneth G Nepple; Yousef Zakharia
Journal:  Drug Des Devel Ther       Date:  2017-04-11       Impact factor: 4.162

Review 2.  Axitinib in the treatment of renal cell carcinoma: design, development, and place in therapy.

Authors:  Audrey Bellesoeur; Edith Carton; Jerome Alexandre; Francois Goldwasser; Olivier Huillard
Journal:  Drug Des Devel Ther       Date:  2017-09-21       Impact factor: 4.162

3.  H1/pAIM2 nanoparticles exert anti-tumour effects that is associated with the inflammasome activation in renal carcinoma.

Authors:  Dafei Chai; Nianli Liu; Huizhong Li; Gang Wang; Jingyuan Song; Lin Fang; Zheng Lu; Hong Yao; Junnian Zheng
Journal:  J Cell Mol Med       Date:  2018-08-30       Impact factor: 5.310
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.